Does high HbA1c indicate prediabetes or diabetes?

HbA1c levels between 5.7-6.4% indicate prediabetes, while 6.5% or higher signals diabetes. This blood test measures your average blood sugar over 2-3 months and helps diagnose these conditions before symptoms appear.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

What is HbA1c and Why Does It Matter?

Hemoglobin A1c (HbA1c) is a blood test that provides a snapshot of your average blood sugar levels over the past two to three months. Unlike a single glucose reading that captures just one moment in time, HbA1c reveals the bigger picture of how well your body manages blood sugar day after day.

This test measures the percentage of hemoglobin proteins in your red blood cells that have glucose attached to them. When blood sugar levels are consistently elevated, more glucose binds to hemoglobin, resulting in a higher HbA1c percentage. Since red blood cells live for about 120 days, the test effectively shows your blood sugar trends over that period.

Understanding your HbA1c is crucial because it can detect prediabetes and diabetes before symptoms appear. Many people with elevated blood sugar feel perfectly fine, which is why this test serves as an early warning system for metabolic dysfunction. Regular monitoring helps you take action before these conditions progress and cause complications.

HbA1c Levels and Their Clinical Significance

HbA1c RangeDiagnosisHealth ImplicationsRecommended Action
Below 5.7%Below 5.7%NormalHealthy blood sugar controlAnnual screening if risk factors present
5.7-6.4%5.7-6.4%PrediabetesIncreased risk of Type 2 diabetes and cardiovascular diseaseLifestyle modifications, test every 6 months
6.5% or higher6.5% or higherDiabetesRisk of complications including heart, kidney, eye, and nerve damageMedical management, quarterly monitoring
Above 8%Above 8%Uncontrolled DiabetesHigh risk of serious complicationsIntensive intervention needed

HbA1c diagnosis requires confirmation with a second test unless symptoms are present with glucose ≥200 mg/dL

HbA1c Ranges: Understanding the Numbers

The American Diabetes Association and other major health organizations use specific HbA1c thresholds to diagnose prediabetes and diabetes. Understanding where your results fall on this spectrum is the first step in taking control of your metabolic health.

Normal Range

An HbA1c below 5.7% is considered normal. This means your blood sugar levels have been well-controlled over the past few months. However, optimal metabolic health often corresponds to levels between 4.8% and 5.4%. Some research suggests that even within the normal range, lower values are associated with better long-term health outcomes.

Prediabetes Range

HbA1c levels between 5.7% and 6.4% indicate prediabetes. At this stage, your blood sugar levels are higher than normal but not yet high enough to be classified as diabetes. This is a critical window for intervention. Studies show that lifestyle changes during the prediabetic phase can prevent or delay the progression to Type 2 diabetes in up to 58% of cases.

Diabetes Range

An HbA1c of 6.5% or higher on two separate tests confirms a diabetes diagnosis. At this level, your body is struggling to manage blood sugar effectively, and medical intervention is typically necessary. The higher the HbA1c, the greater the risk of diabetes-related complications affecting your heart, kidneys, eyes, and nerves.

The Science Behind HbA1c Testing

HbA1c testing works through a process called glycation. When glucose in your bloodstream encounters hemoglobin molecules in red blood cells, they bind together permanently. The higher your blood sugar levels, the more glycated hemoglobin forms. This process is irreversible, which is why the test provides such a reliable long-term view.

The test has several advantages over traditional glucose testing. It doesn't require fasting, making it more convenient for patients. It's also less affected by short-term factors like stress, illness, or what you ate for breakfast. This stability makes HbA1c an excellent tool for both diagnosis and monitoring treatment effectiveness.

However, certain conditions can affect HbA1c accuracy. Anemia, recent blood loss, pregnancy, and certain hemoglobin variants can skew results. Additionally, conditions that affect red blood cell lifespan, such as chronic kidney disease or liver disease, may make the test less reliable. Your healthcare provider should consider these factors when interpreting your results.

Beyond Diagnosis: What Your HbA1c Reveals About Health Risks

Your HbA1c level doesn't just diagnose prediabetes or diabetes—it's also a powerful predictor of future health complications. Research shows that for every 1% increase in HbA1c above normal, the risk of cardiovascular disease increases by approximately 18%. This relationship exists even in the prediabetic range, highlighting the importance of early intervention.

Elevated HbA1c is associated with numerous health risks beyond the classic diabetes complications. These include:

  • Increased inflammation throughout the body
  • Higher risk of cognitive decline and dementia
  • Greater likelihood of developing fatty liver disease
  • Compromised immune function
  • Accelerated aging at the cellular level
  • Increased risk of certain cancers

The good news is that lowering your HbA1c, even by small amounts, can significantly reduce these risks. Studies demonstrate that each 1% reduction in HbA1c correlates with a 37% decrease in microvascular complications and a 14% reduction in heart attack risk.

Factors That Can Influence Your HbA1c Results

While HbA1c is generally a reliable test, several factors can influence your results beyond your actual blood sugar control. Understanding these variables helps ensure accurate interpretation and appropriate treatment decisions.

Medical Conditions

Certain medical conditions can cause falsely high or low HbA1c readings. Iron deficiency anemia often leads to elevated results, while hemolytic anemia can cause falsely low readings. Chronic kidney disease, liver disease, and conditions affecting red blood cell turnover also impact accuracy. Additionally, genetic hemoglobin variants, more common in people of African, Mediterranean, or Southeast Asian descent, may affect standard HbA1c testing methods.

Medications and Supplements

Various medications can influence HbA1c results. High-dose vitamin C and vitamin E supplements may cause falsely low readings. Certain medications used to treat HIV, as well as some psychiatric medications, can affect glucose metabolism and HbA1c levels. Always inform your healthcare provider about all medications and supplements you're taking when discussing your results.

Age and Ethnicity

Research indicates that HbA1c levels tend to increase slightly with age, even in people without diabetes. Some studies suggest that ethnic differences in average HbA1c levels exist independent of blood glucose levels, though the clinical significance of these differences remains debated. These factors underscore the importance of considering individual circumstances when interpreting results.

Taking Action: What to Do If Your HbA1c Is Elevated

Discovering you have prediabetes or diabetes can feel overwhelming, but it's important to remember that you have significant power to influence your metabolic health. The earlier you take action, the better your chances of preventing progression and even reversing prediabetes.

Lifestyle Modifications

For prediabetes and early Type 2 diabetes, lifestyle changes are the first line of defense. The Diabetes Prevention Program study showed that modest lifestyle modifications reduced diabetes risk by 58% over three years. Key interventions include:

  • Losing 5-7% of body weight if overweight
  • Engaging in 150 minutes of moderate exercise weekly
  • Following a balanced diet rich in whole foods
  • Prioritizing sleep quality and duration
  • Managing stress through mindfulness or other techniques
  • Limiting alcohol consumption

Dietary Strategies

Your diet plays a crucial role in managing HbA1c levels. Focus on consuming whole, unprocessed foods with a low glycemic index. Incorporate plenty of non-starchy vegetables, lean proteins, healthy fats, and complex carbohydrates. Consider working with a registered dietitian to create a personalized meal plan that fits your lifestyle and preferences while supporting blood sugar control.

Medical Management

If lifestyle changes alone don't sufficiently lower your HbA1c, medication may be necessary. Metformin is often the first medication prescribed for prediabetes or Type 2 diabetes. Other options include GLP-1 receptor agonists, SGLT2 inhibitors, and various other classes of diabetes medications. Your healthcare provider will consider your individual circumstances, other health conditions, and preferences when recommending treatment.

Monitoring Your Progress: How Often to Test HbA1c

The frequency of HbA1c testing depends on your current levels and treatment plan. For people with normal HbA1c, annual testing is typically sufficient, though those with risk factors may benefit from more frequent monitoring. If you have prediabetes, testing every 6 months helps track whether your interventions are working.

For those with diabetes, the American Diabetes Association recommends testing at least twice yearly if you're meeting treatment goals and have stable blood sugar control. If you're not meeting goals or have recently changed your treatment plan, quarterly testing may be necessary. Some people benefit from more frequent monitoring during periods of lifestyle changes or medication adjustments.

Home testing options now make it easier than ever to monitor your HbA1c without frequent doctor visits. These convenient tests can help you stay on top of your metabolic health and catch changes early, empowering you to make timely adjustments to your health routine.

The Path Forward: Living Well with Optimal Blood Sugar

Whether your HbA1c indicates prediabetes, diabetes, or you're working to maintain normal levels, remember that this number is not your destiny. It's a valuable piece of information that empowers you to make informed decisions about your health. Many people successfully lower their HbA1c through dedicated lifestyle changes, proper medical management, or a combination of both.

The key is to view HbA1c management as a marathon, not a sprint. Sustainable changes that you can maintain long-term are more valuable than drastic measures that you can't stick with. Celebrate small victories, like choosing a walk after dinner or swapping refined grains for whole ones. These seemingly minor choices compound over time to create significant improvements in your metabolic health.

Regular monitoring, whether through your healthcare provider or home testing, keeps you accountable and helps you understand how your body responds to different interventions. By staying informed and proactive, you can optimize your blood sugar control and reduce your risk of complications, ultimately leading to a longer, healthier life.

References

  1. American Diabetes Association. (2024). Standards of Medical Care in Diabetes-2024. Diabetes Care, 47(Suppl 1), S1-S321.[Link][DOI]
  2. Knowler, W. C., Barrett-Connor, E., Fowler, S. E., et al. (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine, 346(6), 393-403.[PubMed][DOI]
  3. Selvin, E., Steffes, M. W., Zhu, H., et al. (2010). Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. New England Journal of Medicine, 362(9), 800-811.[PubMed][DOI]
  4. Nathan, D. M., Kuenen, J., Borg, R., et al. (2008). Translating the A1C assay into estimated average glucose values. Diabetes Care, 31(8), 1473-1478.[PubMed][DOI]
  5. Stratton, I. M., Adler, A. I., Neil, H. A., et al. (2000). Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ, 321(7258), 405-412.[PubMed][DOI]
  6. Tabák, A. G., Herder, C., Rathmann, W., et al. (2012). Prediabetes: a high-risk state for diabetes development. The Lancet, 379(9833), 2279-2290.[PubMed][DOI]

Frequently Asked Questions

How can I test my HbA1c at home?

You can test your HbA1c at home with SiPhox Health's Core Health Program, which includes HbA1c testing along with other essential metabolic markers. This CLIA-certified program provides lab-quality results from the comfort of your home, with testing frequencies available monthly, quarterly, or every 6 months.

What's the difference between HbA1c and regular blood glucose testing?

While regular blood glucose tests show your blood sugar at a single moment, HbA1c reflects your average blood sugar over the past 2-3 months. This makes HbA1c more reliable for diagnosing prediabetes and diabetes, as it's not affected by what you just ate or temporary stress.

Can I reverse prediabetes if my HbA1c is elevated?

Yes, many people successfully reverse prediabetes through lifestyle changes. Research shows that losing 5-7% of body weight, exercising 150 minutes weekly, and following a healthy diet can prevent or delay Type 2 diabetes in up to 58% of people with prediabetes.

How quickly can HbA1c levels change?

Since HbA1c reflects average blood sugar over 2-3 months, it changes gradually. You typically need at least 3 months to see the full impact of lifestyle changes or new medications on your HbA1c levels, though some improvement may be noticeable after 6-8 weeks.

What HbA1c level should I aim for if I have diabetes?

For most adults with diabetes, the American Diabetes Association recommends an HbA1c target below 7%. However, your individual target may vary based on your age, other health conditions, and risk of hypoglycemia. Work with your healthcare provider to determine the right goal for you.

Related Articles

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details